Wegovy Pill Approved as GLP-1 Supply Eases and Pricing Shifts in 2026
Novo Nordisk's oral Wegovy received FDA approval in January 2026. Supply shortages have eased while government pricing deals and weight-regain data reshape the obesity drug market.